Group One Trading
DFTX

Group One Trading’s Definium Therapeutics DFTX Stock Holding History

Group One Trading’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.01M Sell
63,943
-23,889
-27% -$590K ﹤0.01% 1840
2026
Q1 		$1.66M Buy
+87,832
New +$1.49M ﹤0.01% 2238
2024
Q3 		– Sell
-44,365
Closed -$309K – 7074
2024
Q2 		$320K Buy
44,365
+8,007
+22% +$70K ﹤0.01% 2978
2024
Q1 		$342K Sell
36,358
-74,070
-67% -$422K ﹤0.01% 3102
2023
Q4 		$404K Sell
110,428
-24,149
-18% -$72.7K ﹤0.01% 3251
2023
Q3 		$421K Buy
134,577
+84,424
+168% +$347K ﹤0.01% 3074
2023
Q2 		$179K Buy
+50,153
New +$173K ﹤0.01% 4060
2022
Q4 		– Sell
-62,534
Closed -$174K – 7780
2022
Q3 		$219K Buy
62,534
+24,743
+65% +$238K ﹤0.01% 4052
2022
Q2 		$363K Buy
37,791
+2,111
+6% +$26.7K ﹤0.01% 3717
2022
Q1 		$594K Buy
35,680
+3,956
+12% +$68.6K ﹤0.01% 3627
2021
Q4 		$657K Buy
31,724
+21,880
+222% +$698K ﹤0.01% 3818
2021
Q3 		$344K Buy
9,844
+2,371
+32% +$103K ﹤0.01% 4599
2021
Q2 		$387K Buy
+7,473
New +$392K ﹤0.01% 4506

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Group One Trading's DFTX Position: Q2 2026 in Review

Group One Trading reduced its Definium Therapeutics (DFTX) stake by 27% in Q2 2026, selling an estimated $590K and leaving 63,943 shares worth $3.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1840.

Group One Trading first reported a position in DFTX in Q2 2021 and has held it in 13 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Group One Trading held 63,943 shares of Definium Therapeutics worth $3.01M as of Q2 2026.
  • Group One Trading sold 23,889 Definium Therapeutics shares in Q2 2026, an estimated $590K.
  • Definium Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #1840 holding.
  • Group One Trading first reported a position in Definium Therapeutics in Q2 2021 and has held it in 13 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.